title: Multiple myeloma presenting as plasmacytoma of the base of the skull.
authors.forename: A
authors.initials: A
authors.lastname: Alegre
authors.forename: J F
authors.initials: JF
authors.lastname: Tomás
authors.forename: I
authors.initials: I
authors.lastname: Pinilla
authors.forename: J J
authors.initials: JJ
authors.lastname: Gil-Fernández
authors.forename: J M
authors.initials: JM
authors.lastname: Fernández-Rañada
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001536:Bence Jones Protein / Q000652:urine; D001853:Bone Marrow / Q000473:pathology; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003391:Cranial Nerves; D003907:Dexamethasone; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D009408:Nerve Compression Syndromes / Q000209:etiology*; D010954:Plasmacytoma / Q000175:diagnosis*; D012074:Remission Induction; D012888:Skull Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D001536:Bence Jones Protein